Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
CONCLUSION: Patients with T2DM represent almost half of patients with CRS and are younger than their non-diabetic counterparts. T2DM doubles the risk of CRS and increases the risk of death, cardiovascular outcome, and end-stage kidney disease but not ischemic stroke after CRS.PMID:36931430 | DOI:10.1016/j.diabet.2023.101441
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Valentin Maisons Jean-Michel Halimi Gr égoire Fauchier Jean-Baptiste de Fr éminville Nicolas Goin Juliette Gueguen Philippe Gatault B énédicte Sautenet Denis Angoulvant Julien Herbert Arnaud Bisson Pierre-Henri Ducluzeau Laurent Fauchier Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | France Health | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Stroke | Study | Urology & Nephrology